Tags : HSPC

Pfizer and Astellas Amends Clinical Research Protocols of Xtandi for

Shots: The amendments accelerate timelines for the anticipated primary completion dates of both trials ARCHES and EMBARK Phase III trials have been amended its primary completion time from April 2020 to late 2018 and Mar-2021 to mid-2020 respectively In Oct 2009, Pfizer (Medivation) and Astellas entered into a global agreement to jointly develop and commercialize […]Read More